Search Results - "Mason, M. Gary"

Neuroimaging of Peptide-based Vaccine Therapy in Pediatric Brain Tumors by Furtado, Andre D., MD, Ceschin, Rafael, BS, Blüml, Stefan, PhD, Mason, Gary, MD, Jakacki, Regina I., MD, Okada, Hideho, MD, Pollack, Ian F., MD, Panigrahy, Ashok, MD

“…The potential benefits of peptide-based immunotherapy for pediatric brain tumors are under investigation. Treatment-related heterogeneity has resulted in…”
Get full text

JNJ-64041757 (JNJ-757), a Live, Attenuated, Double-Deleted Listeria monocytogenes–Based Immunotherapy in Patients With NSCLC: Results From Two Phase 1 Studies by Brahmer, Julie R., Johnson, Melissa L., Cobo, Manuel, Viteri, Santiago, Sarto, Juan Coves, Sukari, Ammar, Awad, Mark M., Salgia, Ravi, Papadimitrakopoulou, Vali A., Rajan, Arun, Bandyopadhyay, Nibedita, Allred, Alicia J., Wade, Mark, Mason, Gary E., Zudaire, Enrique, Knoblauch, Roland E., Stone, Nicole, Lorenzi, Matthew V., Hassan, Raffit

“…JNJ-64041757 (JNJ-757) is a live, attenuated, double-deleted Listeria monocytogenes–based immunotherapy expressing human mesothelin. JNJ-757 was evaluated in…”
Get full text

Tellurium-centered radical cations. 1. The 1,3-ditellurole radical cation by chemical, electrochemical, and photochemical oxidation by Detty, Michael R, Haley, Neil F, Eachus, Raymond S, Hassett, James W, Luss, Henry R, Mason, M. Gary, McKelvey, John M, Wernberg, Alex A

Get full text